Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 308

The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.

Adoptive regulatory T‐cell therapy protects against cerebral ischemia

Open access
Li, Peiying, Gan, Yu, Sun, Bao‐Liang, Zhang, Feng, Lu, Binfeng, Gao, Yanqin, Liang, Weimin, Thomson, Angus W., Chen, Jun, Hu, Xiaoming · 2013 · Annals of Neurology

Abstract

Objective: Recent evidence suggests that functional deficiency in regulatory T cells (Tregs), an innate immunomodulator, exacerbates brain damage after cerebral ischemia. We therefore evaluated the effect of Treg transfer in rodent models of ischemic stroke and further investigated the mechanism underlying Treg‐afforded neuroprotection. Methods: We examined the therapeutic potential of Tregs and the mechanisms of neuroprotection in vivo in 2 rodent models of ischemic stroke and in vitro in Treg–neutrophil cocultures using a combined approach including cell‐specific depletion, gene knockout mice, and bone marrow chimeras. Results: Systemic administration of purified Tregs at 2, 6, or even 24 hours after middle cerebral artery occlusion resulted in a marked reduction of brain infarct and prolonged improvement of neurological functions lasting out to 4 weeks. Treg‐afforded neuroprotection was accompanied by attenuated blood–brain barrier (BBB) disruption during early stages of ischemia, decreased cerebral inflammation, and reduced infiltration of peripheral inflammatory cells into the lesioned brain. Surprisingly, Tregs exerted early neuroprotection without penetrating into the brain parenchyma or inhibiting the activation of residential microglia. Rather, both in vivo and in vitro studies demonstrated that Tregs suppressed peripheral neutrophil‐derived matrix metallopeptidase‐9 production, thus preventing proteolytic damage of the BBB. In addition to its potent central neuroprotection, Treg treatment was shown to ameliorate poststroke lymphopenia, suggesting a beneficial effect on immune status. Interpretation: Our study suggests that Treg adoptive therapy is a novel and potent cell‐based therapy targeting poststroke inflammatory dysregulation and neurovascular disruption. Ann Neurol 2013;74:458–471

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/ana.23815

Cites

38 of 38 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 38 references

Cited by

See all 308

Metadata

Authors
Li, P., Gan, Y., Sun, B., Zhang, F., Lu, B., Gao, Y., Liang, W., Thomson, A. W., Chen, J., & Hu, X.
Venue
Annals of Neurology
Publisher
Wiley
Published
2013-05-14
Volume
74
Issue
3
Pages
458-471
ISSN
  • 0364-5134 (ISSN-L)
  • 1531-8249
OpenAlex
W1946941723
Cited by
308
References
38
FWCI
6.76
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Adoptive regulatory T‐cell therapy protects against cerebral ischemia. https://app.cochat.ai/papers/10.1002/ana.23815
The paper
Li, P., Gan, Y., Sun, B., Zhang, F., Lu, B., Gao, Y., Liang, W., Thomson, A. W., Chen, J., & Hu, X. (2013). Adoptive regulatory T‐cell therapy protects against cerebral ischemia. Annals of Neurology. https://doi.org/10.1002/ana.23815

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.